Did you know that some of the most extraordinary people in the world aren’t household names? Life is strange in a sense. It seems like the people who don’t do anything for society, receives the credit and vice versa. Have you ever heard of a guy named Clay Siegall? Well, you probably haven’t and this person personifies this notion perfectly. Clay Siegall is one of the most revered individuals in the cancer fighting world. He has a resume of success that spans into decades of the past. Siegall is the current CEO of Seattle Genetics. This biotech company is the leading cancer research company in the world as it specializes in developing and commercializing antibody-based therapies.
Since its inception back in 1998, Seattle Genetics has grown dramatically in physical size as well as employee personnel. There are well over 1,000 people working here, and every person works their job to the very best of their abilities. Siegall is the commander of this ship, which has taken the company into the stratosphere. Its flagship drug ADCETRIS is one of the most successful cancer fighting drugs of all-time. As of today, ADCETRIS has raked in $350 million in earnings. Thanks to Siegall’s ability to negotiate, the drugs are now being used in 65 different countries around the world. This is what obtaining a strategic license can do for a company and Seattle Genetics demonstrates this brilliantly.
Blogging is something that Siegall loves to do in his free time. The guy is constantly updating the community with breaking news in cancer research, and he is known to speak on a wide array of topics. It’s easy to see why this guy is a leader, and his track record is proof of his success. His dedication to each and every patient is extraordinary, which shows you how much he has invested in what he does for a living. Clay Siegall is the real deal when it comes to getting things done thanks to his passion, desire and excellence.